# Development of Renal Cysts after Crizotinib Treatment in Advanced ALK-Positive Non–Small-Cell Lung Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/development-of-renal-cysts-after-crizotinib-treatment-in-advanced-alk-positive/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yen‐Ting Lin,Yu‐Fen Wang,James Chih‐Hsin Yang,Chong‐Jen Yu,Shang‐Gin Wu,Jin‐Yuan Shih,Pan‐Chyr Yang |
| Citations | 65 |
| DOI | 10.1097/jto.0000000000000326 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | http://www.jto.org/article/S1556086415307449/pdf |
| OpenAlex ID | https://openalex.org/W2093366431 |
| PMID | 25436806 |
| Type | article |
| Year | 2014 |

## Paper authors

- [Yen‐Ting Lin](https://scholariq.org/researchers/yen-ting-lin/)

## Paper journal

- [Journal of Thoracic Oncology](https://scholariq.org/journals/journal-of-thoracic-oncology/)

## Paper primary topic

- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)

## Paper topics

- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Tuberous Sclerosis Complex Research](https://scholariq.org/topics/tuberous-sclerosis-complex-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.